OKYO Pharma

Europe Legal Chronicle. June 1, 2022

OKYO Pharma’s U.S. Initial Public Offering

By Martina Bellini

Orrick advised OKYO Pharma on the deal. OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

GameAbove Sports’ Acquisition of Ownership Stake in Brisbane Bullets

Lee Health’s Conversion to Private, Nonprofit Health System

Green Theme Technologies’ $6 Million Series C Financing Round

MS Private Credit Administrative Services’ $20 Million Investment in Novopayment

Ivi Energia’s R$150 Million Debentures Issuance

CNH Industrial Capital Argentina’s US$28 Million Notes Issuance

LVMH’s Acquisition of a Minority Stake in Our Legacy

rEvolution’s Acquisition of WePlay

Netrics’ Acquisition Of Solify GmbH

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Rönesans Holding’s €456 Million Healthcare Project in Kazakhstan

Turkey Wealth Fund’s Sukuk Issuance

ADQ’s Acquisition of Odea Bank

Cello World’s Merger with Wim Plast

Intudo’s US$125 Million Closing of Intudo Ventures IV and Natural Resources Fund

Downhole Products Limited’s Acquisition of Sledgehammer Oil Tools Private Limited

Pérez Alati, Grondona, Benites & Arntsen (PAGBAM) and Saravia Frías Abogados (SFA) enter into a collaboration agreement

Barnes & Thornburg Names Scott Simmonds as Intellectual Property Department Chair

Aloke Chakravarty Joins Saul Ewing’s Boston Office

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

OKYO Pharma’s U.S. Initial Public Offering

Standard 1 Year Membership Required